Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Huanrong Ma

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
BMJ Open|June 27, 2022
Prevalence of breast fibroadenoma in healthy physical examination population in Guangdong province of China: a cross-sectional studyLijun Zhu, Xiaoqi Zeng, Shanshan Jiang, et al.
Biomacromolecules|October 20, 2015
Theranostic, pH-Responsive, Doxorubicin-Loaded Nanoparticles Inducing Active Targeting and Apoptosis for Advanced Gastric CancerHuanrong Ma, Yuqing Liu, Min Shi, et al.
Integrative Cancer Therapies|September 30, 2021
Inhibition of Glutamine Uptake Improves the Efficacy of Cetuximab on Gastric CancerHuanrong Ma, Jingjing Wu, Minyu Zhou, et al.
Oncology Letters|August 22, 2018
Impact of liver tumor percutaneous radiofrequency ablation on circulating tumor cellsYang Li, Na Huang, Chunlin Wang, et al.
Oncotarget|May 7, 2015
MiR-338-3p inhibits epithelial-mesenchymal transition in gastric cancer cells by targeting ZEB2 and MACC1/Met/Akt signalingNa Huang, Zhenzhen Wu, Li Lin, et al.
Pharmaceutics|August 26, 2022
Gold Nanoclusters-Based NIR-II Photosensitizers with Catalase-like Activity for Boosted Photodynamic TherapyQing Dan, Zhen Yuan, Si Zheng, et al.
Redox Biology|March 5, 2024
Covalent organic framework based cytoprotective therapy after ischemic strokeYuqin Peng, Qingfan Ren, Huanrong Ma, et al.
Translational Stroke Research|August 1, 2025
Serum Metabolome Profiling Reveals Biomarkers to Predict Malignant Brain Edema Following Endovascular Stroke TherapyJiaqi Luo, Xiaolin Zhao, Mengxuan Xiao, et al.
Cancer Letters|February 23, 2017
IGF1/IGF1R/STAT3 signaling-inducible IFITM2 promotes gastric cancer growth and metastasisLi Xu, Rui Zhou, Lezhong Yuan, et al.
International Journal of Cancer|January 25, 2018
Inhibition of SLC1A5 sensitizes colorectal cancer to cetuximabHuanrong Ma, Zhenzhen Wu, Jianjun Peng, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
BMJ Open|June 27, 2022
Prevalence of breast fibroadenoma in healthy physical examination population in Guangdong province of China: a cross-sectional studyLijun Zhu, Xiaoqi Zeng, Shanshan Jiang, et al.
Biomacromolecules|October 20, 2015
Theranostic, pH-Responsive, Doxorubicin-Loaded Nanoparticles Inducing Active Targeting and Apoptosis for Advanced Gastric CancerHuanrong Ma, Yuqing Liu, Min Shi, et al.
Integrative Cancer Therapies|September 30, 2021
Inhibition of Glutamine Uptake Improves the Efficacy of Cetuximab on Gastric CancerHuanrong Ma, Jingjing Wu, Minyu Zhou, et al.
Oncology Letters|August 22, 2018
Impact of liver tumor percutaneous radiofrequency ablation on circulating tumor cellsYang Li, Na Huang, Chunlin Wang, et al.
Oncotarget|May 7, 2015
MiR-338-3p inhibits epithelial-mesenchymal transition in gastric cancer cells by targeting ZEB2 and MACC1/Met/Akt signalingNa Huang, Zhenzhen Wu, Li Lin, et al.
Pharmaceutics|August 26, 2022
Gold Nanoclusters-Based NIR-II Photosensitizers with Catalase-like Activity for Boosted Photodynamic TherapyQing Dan, Zhen Yuan, Si Zheng, et al.
Redox Biology|March 5, 2024
Covalent organic framework based cytoprotective therapy after ischemic strokeYuqin Peng, Qingfan Ren, Huanrong Ma, et al.
Translational Stroke Research|August 1, 2025
Serum Metabolome Profiling Reveals Biomarkers to Predict Malignant Brain Edema Following Endovascular Stroke TherapyJiaqi Luo, Xiaolin Zhao, Mengxuan Xiao, et al.
Cancer Letters|February 23, 2017
IGF1/IGF1R/STAT3 signaling-inducible IFITM2 promotes gastric cancer growth and metastasisLi Xu, Rui Zhou, Lezhong Yuan, et al.
International Journal of Cancer|January 25, 2018
Inhibition of SLC1A5 sensitizes colorectal cancer to cetuximabHuanrong Ma, Zhenzhen Wu, Jianjun Peng, et al.
Pageof 1